Insulet

IPO

Insulet is a healthcare company in Acton, United States, founded in 2000. It has raised $103.0M across 5 rounds, most recently a $50.0M Series E in February 2006.

Born of empathy, driven by ingenuity, proven by science

Employees
1001–5000
Founded
2000
Business Model
B2B2C
Total Funding
$103.0M
Last Round
$50.0M Series EFeb 2006
Rounds
5
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds and 6 investors for this company. The full record is or through the API.

About

Insulet Corporation (NASDAQ: PODD) is an innovative medical device company headquartered in Acton, Massachusetts, dedicated to transforming the lives of people with diabetes and other conditions through its Omnipod product platform. Founded in 2000, Insulet pioneered the tubeless, waterproof Omnipod insulin pump system, which eliminates the need for multiple daily injections and the tubing associated with traditional pumps. The Omnipod 5 is the first tubeless automated insulin delivery system. Insulet's products are accessible in 25 countries across North America, Europe, the Middle East, and Asia Pacific.

Summary

It lists 1001–5000 employees. It has raised $103.0M in total across 5 rounds, most recently a $50.0M Series E round in Feb 2006. Investors include Prism Venture Partners, Kodiak Venture Partners and OrbiMed.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
IPOMay 2007
$120.0M

Sign up to see all 6 events

Funding: Seed through Series E. Amounts, valuations, and investors where available.

Investors

Similar Companies

PHC

PHC is a leading provider of diabetes monitoring systems, specialized laboratory equipment, and c...

Minato, Japan5001–10000Healthcare, Life Sciences
Private EquityTotal funding$1.9BMar 2021
MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014
The Bountiful CompanyAcquired

American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...

Ronkonkoma, United States1001–5000Healthcare, Retail
Private EquityTotal funding$7.0BJul 2017
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
OneOncologyAcquired

OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

Nashville, United States1001–5000Healthcare, Data & Analytics
Extension RoundTotal funding$5.1BDec 2025
Canopy Growth Corporation Common SharesIPO

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...

Smiths Falls, Canada1001–5000Healthcare
Corporate RoundTotal funding$4.5BJan 2024

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Insulet on Indexed.vc
<a href="https://indexed.vc/companies/insulet"><img src="https://indexed.vc/api/badge/company/insulet" alt="Insulet on Indexed.vc" width="260" height="76" /></a>